The firm detailed plans for its multiple sclerosis drug and the IPO trajectory of its subsidiary, unbuzzd.
Live Poll
Do you believe pharmaceutical companies are successfully developing better treatments for chronic conditions?
September 29, 2026
Tiny Health Raised $33 Million for Microbiome DataThe company secured funding to scale its clinical research and business-to-business platform for practitioners.
September 22, 2026
AlphaRose Therapeutics Secured Grant for Bain SyndromeThe funding supports advancing the drug candidate Rosiphersen toward an Investigational New Drug application.
